All manufacturing activities of Marion Biotech’s Noida unit stopped after inspection

All manufacturing activities at Marion Biotech's Noida unit have been halted by the Union health ministry as India launches a probe into deaths linked to cough syrup in Uzbekistan.

Important facts

Further investigations are underway into the deaths of 18 children in Uzbekistan allegedly linked to cough syrup.
Samples of the cough syrup have been taken from the manufacturing premises in Noida and sent to the Regional Drugs Testing Laboratory (RDTL) in Chandigarh for testing.
The Central Drugs Standard Control Organization (CDSCO) is in regular touch with the national drug regulator of Uzbekistan regarding the matter which happened on 27 December.
Marion Biotech does not sell Dok-1 Max in India and its only export has been to Uzbekistan.

About Marion Biotech

Marion Biotech is a licensed manufacturer and holds the licence for manufacturing Dok-1 Max syrup and tablets for export purposes granted by the Drugs Controller.
So far, 18 out of 21 children with acute respiratory illness have died after taking Dok-1 Max Syrup.
Ethylene glycol was found in the tested series of Doc-1 Max syrup.
Prior to the incident in Uzbekistan, the death of 70 children in Gambia earlier this year was linked to cough syrup manufactured by Haryana-based Maiden Pharmaceuticals.

Please Rate this article, so that we can improve the quality for you -

Date Wise Search